Efficacy and Tolerability Of Frontline Oral Fludarabine and Cyclophosphamide Combination Therapy For Elderly Patients With Chronic B-Cell Lymphocytic Leukaemia and Low Grade Non Hodgkin Lymphoma

被引：0
|
作者：
Bergamaschi, Micaela
Mitscheunig, Laura
Guolo, Fabio
Ghiso, Anna
Galaverna, Federica
Miglino, Maurizio
Clavio, Marino
Ballerini, Filippo
Canepa, Letizia
Lemoli, Roberto
Gobbi, Marco
Pierri, Ivana
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.5095.5095
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5095
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EFFICACY, TOLERABILITY, COST-SAVING OF FRONTLINE ORAL FLUDARABINE AND CYCLOPHOSPHAMIDE COMBINATION THERAPY FOR CHRONIC B-CELL LYMPHATIC LEUKAEMIA AND LOW GRADE NON HODGKIN LYMPHOMA ELDERLY PATIENTS
    Bergamaschi, M.
    Ghiso, A.
    Miglino, M.
    Clavio, M.
    Ballerini, F.
    Canepa, L.
    Galaverna, F.
    Grosso, R.
    Gobbi, M.
    Pierri, I.
    HAEMATOLOGICA, 2012, 97 : 527 - 528
  • [2] Combined therapy with Fludarabine and Cyclophosphamide in relapsed/resistant patients with B-cell chronic lymphocytic leukaemia and non-Hodgkin's lymphomas
    Zaja, F
    Rogato, A
    Russo, D
    Marin, L
    Silvestri, F
    Baccarani, M
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1997, 59 (05) : 327 - 328
  • [3] THE COMBINATION OF LOW DOSES FLUDARABINE & CYCLOPHOSPHAMIDE AS FRONTLINE TREATMENT FOR ELDERLY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Pierri, I.
    Olcese, F.
    Cagnetta, A.
    Bergamaschi, M.
    Gobbi, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 527 - 527
  • [4] THE EFFICACY OF FLUDARABINE AND CYCLOPHOSPHAMIDE COMBINATION IN UNTREATED VS PRETREATED PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
    Milosevic, V.
    Bogunovic, M.
    Jankovic, S.
    Antic, D.
    Tomin, D.
    Todorovic, M.
    Kurtovic, N. Kraguljac
    Jovanovic, M. Perunicic
    Bogdanovic, A.
    Mihaljevic, B.
    Gotic, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 527 - 527
  • [5] Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy
    Marotta, G
    Bigazzi, C
    Lenoci, M
    Tozzi, M
    Bocchia, M
    Lauria, F
    HAEMATOLOGICA, 2000, 85 (12) : 1268 - 1270
  • [6] Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia
    Foran, JM
    Oscier, D
    Orchard, J
    Johnson, SA
    Tighe, M
    Cullen, MH
    de Takats, PG
    Kraus, C
    Klein, M
    Lister, TA
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1574 - 1579
  • [7] Fludarabine, cyclophosphamide and mitoxantrone in relapsed or refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma
    Hendry, L
    Bowen, A
    Matutes, E
    Swansbury, J
    Catovsky, D
    LEUKEMIA & LYMPHOMA, 2004, 45 (05) : 945 - 950
  • [8] Efficacy and safety of fludarabine and cyclophosphamide combined therapy in patients with refractory/recurrent B-cell chronic lymphocytic leukaemia (B-CLL) - Polish multicentre study
    Kowal, M
    Dmoszynska, A
    Lewandowski, K
    Hellmann, A
    Wegrzyn, J
    Skotnicki, AB
    Wolowiec, D
    Kuliczkowski, K
    Piszcz, J
    Kloczko, J
    Roznowski, K
    Komarnickif, M
    LEUKEMIA & LYMPHOMA, 2004, 45 (06) : 1159 - 1165
  • [9] Low-dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and relapsed or refractory chronic lymphocytic Leukaemia
    Forconi, Francesco
    Fabbri, Alberto
    Lenoci, Mariapia
    Sozzi, Elisa
    Gozzetti, Alessandro
    Tassi, Maristella
    Raspadori, Donatella
    Lauria, Francesco
    HEMATOLOGICAL ONCOLOGY, 2008, 26 (04) : 247 - 251
  • [10] All is not lost - the improving outcome of patients with chronic lymphocytic leukaemia failing frontline therapy with fludarabine, cyclophosphamide and rituximab
    Cheah, Chan Y.
    Lew, Thomas E.
    Lee, Rebecca
    Tam, Constantine S.
    Seymour, John F.
    Carney, Dennis A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 91 (02) : 189 - 190
12345